Skip to main content

. 1989 Jan;26(1):69–70. doi: 10.1136/jmg.26.1.69-a

Teratogenicity of ergotamine.

PMCID: PMC1015547 PMID: 2918535

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Czeizel A., Pázsy A., Pusztai J., Nagy M. Aetiological monitor of congenital abnormalities: a case-control surveillance system. Acta Paediatr Hung. 1983;24(1):91–99. [PubMed] [Google Scholar]
Hughes H. E., Goldstein D. A. Birth defects following maternal exposure to ergotamine, beta blockers, and caffeine. J Med Genet. 1988 Jun;25(6):396–399. doi: 10.1136/jmg.25.6.396. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES